	The Copper-Gut-Brain Axis: A Triple Inflammatory Pathway Driving Neuroinflammation in Alzheimer's Disease. Aging Dis Ambi A. PMID: 42149101 [PubMed - as supplied by publisher]
	Therapeutic Landscape of Early Symptomatic Alzheimer's Disease Translated into Everyday Practice for Geriatric Providers. Clin Interv Aging Bailey-Taylor MJ, Morrow P, Hendrix J, Galluzzi KE, Sharafsaleh G. PMID: 42148368 [PubMed - indexed for MEDLINE]
	Development of coumarin-sulfonate scaffolds for cholinesterase inhibition: experimental and computational studies toward Alzheimer's disease therapy. RSC Adv Mughal EU, Naeem N, Cheema AS, Othman GA, Sadiq A, Bayrak S, K, Hawsawi MB, Gomha SM, Almaz Z. PMID: 42148273 [PubMed]
	Anti-AÎ²3-10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-ÎºB pathway. Front Immunol You J, Liu Q, Li X. PMID: 42148080 [PubMed - indexed for MEDLINE]
	The adaptation and evaluation of a culturally grounded lifestyle intervention to mitigate the risk of Alzheimer's disease and related dementias in Native Hawaiians and Pacific Islanders: A study protocol. SSM Ment Health Kaholokula JK, Buchwald D, MacLehose R, Look M, de Silva M, Worthington Antonio JK, Desimone K, Yoshimura S, Dillard A, Kenney M, Keali, Purdy M. PMID: 42147774 [PubMed]
	Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease. Res Sq Armstrong AM, O'Brien EK, Fernandez SM, Doré V, Bourgeat P, Shishegar R, Maruff P, Rowe CC, Villemagne VL, Initiative TADN, Group TAR, Porter T, Laws SM. PMID: 42147167 [PubMed]
	A Cell-Type-Resolved Meta-Analysis Reveals Glial DNA Methylation Changes Associated with Aging and Alzheimer's Disease. bioRxiv Bhaskar U, Kos MZ, Carless MA. PMID: 42146576 [PubMed]
	A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study. bioRxiv Lutz MW, Man Z, Zheng Y, Venkatesan S, Chiba-Falek O. PMID: 42146366 [PubMed]
	Epigenetic Modulation Is a Key Mechanism in Cognitive Deficit: Unveiling Garcinol as a Potent HAT Inhibitor in Improving Alzheimer's Disease. ACS Omega Mishra A, Satapathy BS, Sahu PK, Ghose A, Paidesetty SK. PMID: 42146238 [PubMed]
	A data-driven Alzheimer's disease progression simulator for retrospective validation and prospective Phase III power design. medRxiv Lorenzi M, Custo A, Frisoni GB, Garibotto V. PMID: 42145636 [PubMed]
	A Genome-wide Association Study of Alzheimer's Disease and Dementia in a Large Multi-ancestry Military Cohort Identifies Many New Dementia-Associated Loci. medRxiv Sherva R, Bayly H, Zhang R, Harrington K, Mez J, Miller MW, Tsuang D, Wolf E, Zeng Q, Le Guen Y, Tejeda M, VA Million Veteran Program, MVP Cognitive Decline, Dementia During Aging Working Group, Gaziano JM, Panizzon MS, Hauger RL, Merritt VC, Farrer LA, Logue MW. PMID: 42145619 [PubMed]
	Multi-Target-Directed Ligands (MTDLs) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease. CNS Neurosci Ther Jung J, Kim Y, Cirunduzi AC, Yoon S, Bang S, Yang SH. PMID: 42145047 [PubMed - indexed for MEDLINE]
	Formulaic and novel language dissociate in Alzheimer's clinical syndrome: evidence for the Dual-Process Model. J Clin Exp Neuropsychol Budrovic K, Gunstad J, Hamrick P. PMID: 42143738 [PubMed - as supplied by publisher]
	Knowledge, attitude, and practice toward Alzheimer's disease prevention among middle-aged and elderly individuals: a cross-sectional study. Dement Geriatr Cogn Disord Wu F, Yang C, Wu F, Sun Z. PMID: 42142345 [PubMed - as supplied by publisher]
	Exploring the Expression Changes of Immune Genes in Alzheimer's Disease: A Study on ANXA1, VCAM1, and CCL2. Mol Neurobiol Fattahi F, Abed S, Kouchakali G, Derakhshan SM, Sadeh RN, Khaniani MS. PMID: 42142197 [PubMed - indexed for MEDLINE]
	Ginsenosides for Multi-target Intervention in Alzheimer's Disease: Current Evidence, Challenges, and Future Directions. Mol Neurobiol Oriquat G, Ali AM, H M, Ahmad IA, Maharana L, Chauhan AS, Arora V, Purohit B, Kumar-Mishra M. PMID: 42141250 [PubMed - indexed for MEDLINE]
	Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia. Acta Neuropathol Flores-Aguilar L, Zaikos TD, Rivera I, Wright ST, Lou J, Gawronski B, Gonzalez L, Berry JV, Rouanet J, Edwards NC, Hoang DK, Wood K, Granholm AC, Mufson EJ, Monuki ES, Ikonomovic MD, Kofler J, Doran EW, Lott IT, Totoiu MO, Hom CL, Lai F, Yong WH, Schmitt FA, Harp J, Nelson PT, Gutierrez J, Lao PJ, Wilcock DM, Brickman AM, Head E, Alzheimer. PMID: 42141233 [PubMed - indexed for MEDLINE]
	Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized, placebo-controlled, clinical trial in three parallel groups. Sci Rep Gorin BI, Pozdnyakov SO, Potapova KA, Tukhovskaya EA, Gorchakov DS. PMID: 42141012 [PubMed - in process]
	Nitric Oxide Signaling in Alzheimer's Disease: A Double-Edged Sword. Eur J Pharmacol Wasim R. PMID: 42140516 [PubMed - as supplied by publisher]
	Cell-type-specific APOE4 cascade across the Alzheimer's disease continuum. Neuron Shostak D, Liang Z, Huang Y. PMID: 42140183 [PubMed - as supplied by publisher]

Articles 1 - 20 / 70436

Page 1 of 3522



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy